What D49 covers · when clinicians use it
ICD-10 code D49 identifies Neoplasms of unspecified behavior in the U.S. ICD-10-CM clinical and billing record set. It sits within the Neoplasms chapter (C00–D49), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply D49 when an encounter's findings match the Neoplasms of unspecified behavior description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify D49 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for D49 and is a coding reference, not clinical, diagnostic, or billing advice.
D49 refers to Neoplasms of unspecified behavior, a category of neoplasms that either originate from hormone-secreting neuroendocrine cells and are confirmed to be benign (D3A), or those whose behavior—benign or malignant—cannot be clearly determined at diagnosis (D49). These codes help flag uncertain or low-risk tumors for observation and follow-up.
Symptoms
- Incidental mass – Often found on imaging with no symptoms
- Hormonal imbalance – Seen in benign neuroendocrine tumors (e.g., carcinoid, insulinoma)
- Non-specific discomfort – Pressure or mild pain in tumor region
- Flushing or diarrhea – Linked to hormonally active tumors
- Stable growth – Tumors that remain unchanged over time
- No systemic signs – Typically no weight loss, fever, or major dysfunction
- Normal lab tests – Bloodwork may not show malignant indicators
Diagnosis
Diagnosis of Neoplasms of unspecified behavior involves imaging (CT, MRI, nuclear scans), hormonal testing (if neuroendocrine-related), and biopsy. These tumors are often monitored over time to assess behavior, growth, or potential need for intervention, especially if initial pathology results are inconclusive or benign.
ICD10 Code Usage
ICD10 code D49 is used when documentation requires classification of a neoplasm as benign or undefined in its behavior. It is important in surgical, endocrine, radiology, and oncology workflows to guide next steps, insurance documentation, and care planning.
Related Codes
FAQs
Q1: What is ICD10 code D49?
A: It refers to Neoplasms of unspecified behavior, used to document either benign neuroendocrine tumors (D3A) or neoplasms with unclear behavior (D49).
Q2: Are these cancer?
A: No, D3A is benign, and D49 is unspecified—neither are definitively malignant unless reclassified later.
Q3: Are these tumors removed?
A: Only if symptomatic, growing, or suspicious. Many are monitored over time.
Q4: What does “unspecified behavior” mean?
A: It means there isn’t enough evidence to classify the tumor as benign or malignant.
Q5: Should these be followed up?
A: Yes, regular surveillance is usually recommended to detect changes in behavior.
Conclusion
ICD10 code D49 is essential for accurately documenting Neoplasms of unspecified behavior. It supports clinical decision-making, follow-up care, and billing processes when a tumor is either confirmed benign (D3A) or its biological behavior remains uncertain (D49).